FDA says this weight loss drug shortage is over, but ... - CBS News
Oct 23, 2024 · Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies …
Tirzepatide cuts risk of diabetes by 94% in adults with ... - CNN
Aug 20, 2024 · A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and …
Mounjaro leads to significantly more weight loss than Ozempic, …
Jul 8, 2024 · People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study. …
News Release - Eli Lilly and Company
FDA approves Lilly's Mounjaro™ (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes. Mounjaro delivered superior A1C …
Nurse's death linked to weight-loss drug Mounjaro approved on …
Nov 8, 2024 · BBC. Susan McGowan died two weeks after taking tirzepatide - brand name Mounjaro. The death of a nurse from North Lanarkshire has been linked to the use of a weight …
FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity ... - CNN
Nov 8, 2023 · The drug, called Mounjaro for diabetes, will be called Zepbound for weight loss, according to a news release from the FDA. Made by Eli Lilly, it’s part of a new class of drugs …
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free
1 day ago · Weekly tirzepatide (Zepbound and Mounjaro) injections (pooled 5 mg, 10 mg, 15 mg doses) significantly reduced the risk of progression to type 2 diabetes in adults with pre …
FDA Says Mounjaro, Zepbound Shortage Has Ended: What to Know - Healthline
Aug 7, 2024 · Zepbound and Mounjaro have been on the Food and Drug Administration's shortage list for months. In response, manufacturer Eli Lilly spent billions ramping up …
A new version of the diabetes drug Mounjaro can ... - Associated Press News
Nov 8, 2023 · A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration …
New obesity drug Mounjaro poised to surpass Ozempic, Wegovy | AP News
Apr 27, 2023 · Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity …